Education
About Us
Working with TipRanks
Follow Us
AnGes Inc (JP:4563)
:4563
4563 Stock Chart & Stats
¥87.00
¥1.00(1.89%)
At close: 4:00 PM EST
¥87.00
¥1.00(1.89%)
Day’s Range― - ―
52-Week Range¥46.00 - ¥120.00
Previous CloseN/A
Volume2.84M
Average Volume (3M)6.28M
Market Cap
$33.20B
Enterprise Value¥18.46B
Total Cash (Recent Filing)$2.68B
Total Debt (Recent Filing)$219.96M
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Nov 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.08
Shares Outstanding386,077,550
10 Day Avg. Volume3,524,530
30 Day Avg. Volume6,279,363
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)5.78
Price to Sales (P/S)19.40
P/FCF Ratio-1.86
Enterprise Value/Market Cap0.56
Enterprise Value/Revenue26.40
Enterprise Value/Gross Profit79.50
Enterprise Value/Ebitda-3.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4563 FAQ
What was AnGes Inc’s price range in the past 12 months?
AnGes Inc lowest stock price was ¥46.00 and its highest was ¥120.00 in the past 12 months.
What is AnGes Inc’s market cap?
AnGes Inc’s market cap is $33.20B.
When is AnGes Inc’s upcoming earnings report date?
AnGes Inc’s upcoming earnings report date is Nov 07, 2025 which is tomorrow.
How were AnGes Inc’s earnings last quarter?
AnGes Inc released its earnings results on Aug 08, 2025. The company reported -¥8.08 earnings per share for the quarter, missing the consensus estimate of N/A by -¥8.08.
Is AnGes Inc overvalued?
According to Wall Street analysts AnGes Inc’s price is currently Overvalued.
Does AnGes Inc pay dividends?
AnGes Inc does not currently pay dividends.
What is AnGes Inc’s EPS estimate?
AnGes Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnGes Inc have?
AnGes Inc has 386,077,550 shares outstanding.
What happened to AnGes Inc’s price movement after its last earnings report?
AnGes Inc reported an EPS of -¥8.08 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.589%.
Which hedge fund is a major shareholder of AnGes Inc?
Currently, no hedge funds are holding shares in JP:4563
Company Description
AnGes Inc
AnGes (4563) is a biotechnology company based in Japan that focuses on the development of innovative therapies and technologies for the treatment of various diseases, particularly in the fields of gene therapy and regenerative medicine. The company operates in sectors such as pharmaceuticals and biotechnology, with core products that include gene therapies for rare genetic disorders and advanced regenerative medicine solutions aimed at enhancing tissue repair and regeneration.
Technical Analysis
CanBas Co., Ltd.
―
Healios KK
―
StemRIM Inc.
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―
Options Prices
Currently, No data available
---